High-Definition DNA Methylation Profiles from Breast and Ovarian Carcinoma Cell Lines with Differing Doxorubicin Resistance
Michael Boettcher, Frank Kischkel, Jörg D. Hoheisel · 2010
Read High-Definition DNA Methylation Profiles from Breast and Ovarian Carcinoma Cell Lines with Differing Doxorubicin Resistance by Michael Boettcher, Frank Kischkel, Jörg D. Hoheisel (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0011002.txt.
Description
Michael Boettcher, Frank Kischkel and Jörg Hoheisel published this cancer epigenetics study in PLOS ONE in 2010. Cancers that survive chemotherapy are a leading cause of treatment failure, and abnormal DNA methylation, chemical silencing tags on genes, is increasingly blamed for helping tumors resist drugs. The authors profiled those tags in breast and ovarian cancer cell lines with differing resistance to doxorubicin.
They measured methylation at hundreds of sites around the start regions of twenty-eight genes already linked to drug resistance or tumor progression. Comparing sensitive and resistant lines at that resolution reveals which silencing patterns travel with resistance. Boettcher and colleagues treat methylation as a readable record of how tumors adapt to chemotherapy. Such profiles could one day warn doctors that a cancer is learning to resist before scans show it growing again.
Catalog record
| CREATOR | Michael Boettcher, Frank Kischkel, Jörg D. Hoheisel |
|---|---|
| YEAR | 2010 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 43 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0011002